Spark Therapeutics Aktie
-
Deine Einschätzung
Was spricht für und gegen Spark Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Spark Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| United Therapeutics | 1,49 % | 13,96 % | 17,06 % | 66,63 % | 9,85 % | 124,16 % | 250,30 % |
| Iovance Biotherapeutics Inc. | -1,52 % | -21,72 % | 59,72 % | 6,63 % | 46,02 % | -42,79 % | -88,07 % |
| Ligand Pharmaceuticals | -6,25 % | 1,67 % | 16,56 % | 69,44 % | 10,24 % | 191,77 % | 33,09 % |
Kommentare
News
The Quiet Retail Compounder Investors Keep Buying on Every Dip
Casey’s General Stores (NASDAQ: CASY) is a long-term retail holding that has tended to reward a buy-the-dip strategy. This company is as quality as they come, internally funding growth
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December



